Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Lexicon Pharmaceuticals, Inc.    LXRX

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 3,08 M
EBIT 2015 -117 M
Net income 2015 -125 M
Debt 2015 50,0 M
Yield 2015 -
Sales 2016 57,3 M
EBIT 2016 -116 M
Net income 2016 -120 M
Debt 2016 39,0 M
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
EV / Sales 2015 298x
EV / Sales 2016 15,8x
Capitalization 868 M
More Financials
Company
Lexicon Pharmaceuticals, Inc. engages in discovery and development of breakthrough treatments for human disease.The company primarily focuses on the discovery of the functions and pharmaceutical utility of genes and the use of those gene function discoveries in the discovery and development of... 
More about the company
Surperformance© ratings of Lexicon Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on LEXICON PHARMACEUTICALS, I
01/14 LEXICON PHARMACEUTICALS : To Present At The 34th Annual J.P. Morgan Healthcare C..
2015 LEXICON PHARMACEUTICALS : To Present At The Oppenheimer 26th Annual Healthcare C..
2015 LEXICON PHARMACEUTICALS : Assigned Patent
2015 LEXICON PHARMACEUTICALS : Telotristat Etiprate Achieves Positive Top-line Result..
2015 LEXICON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Cond..
2015DJLexicon, Sanofi Agree to Diabetes Drug Pact
2015 LEXICON PHARMACEUTICALS : reports 3Q loss
2015 Sanofi sees strong profit growth from 2018, to cut costs
More news
Sector news : Bio Therapeutic Drugs
08:52a AMGEN : Kyprolis launches in the UK for relapsed multiple myeloma
02/11 LONZA : Education Great Bay, UNH Manchester offer biotech program Department of ..
02/11 FDA panel recommends approval for copy of arthritis drug Remicade
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
2015 SEEKING ALPHA'S BIOTECH WEEKLY : A Gilead Victory, Celladon Crumbles, And More
2015 Lexicon Undervalued As It Approaches A Major Event
2015 Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q1 2015 Results - Earning..
2015 Lexicon Pharmaceuticals EPS in-line, beats on revenue
2015 Lexicon Pharmaceuticals - A Diamond In The Rough?
Comments 
Advertisement
Chart LEXICON PHARMACEUTICALS, I
Duration : Period :
Lexicon Pharmaceuticals, I Technical Analysis Chart | LXRX | US5288721047 | 4-Traders
Full-screen chart
Technical analysis trends LEXICON PHARMACEU...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions